This report provides analysis of bioinformatics market over three major segments, namely tools, content/database and service. It further analyzes each macro market with respect to sub segments from the market prospective. It also gives a qualitative and quantitative view of the bioinformatics market over major geographical regions.
Scope of this research
- Analysis of the market data of bioinformatics tools, services and content/database in North America, Europe, Asia and RoW.
- Provides patent analysis with respect to competitors, geography and technology while analyzing them over the years.
- Describes the strategic focus of the market players by evaluating the competitive landscape within the bioinformatics market.
- Analyzes the markets while giving an overview of Indian and Chinese bioinformatics industry and mutually comparing them.
Research and analysis highlights
Growth trends between 2005 and 2008 in food and drinks products offering preventive health benefits include brain and mental health (from 7.6% to 13.1%) and digestive, defense and immunity (from 8.5% to 12.2%).
Contradictory trends within the cultures and lifestyles of many major market countries mean that there are future growth opportunities in both elements of the mind and mood health trend. One way forward for manufacturers is to offer product lines with varieties to appeal to concerns of consumers for both 'up' benefits and 'down' benefits.
Latin America is emerging as an important region for new product development in preventive health food and drink, with its share of NPD rising from 3.3% in 2005 to 6.6% in 2008.
Key reasons to purchase this research
- Understand the emerging technologies and the growth associated for evaluation of potential of the type of product and services.
- Understanding the product developments on which the companies are focusing for evaluating the new technological trends.
- For evaluation of growth prospective for the bioinformatics applications and determining the lucrative markets.
- To gain knowledge about the relative importance of the bioinformatics tools in the next five years for investment opportunities.